185 related articles for article (PubMed ID: 1649189)
21. Cytosolic and sarcoplasmic reticulum-associated low Km, cGMP-inhibited cAMP phosphodiesterase in mammalian myocardium.
Smith CJ; Krall J; Manganiello VC; Movsesian MA
Biochem Biophys Res Commun; 1993 Jan; 190(2):516-21. PubMed ID: 8381278
[TBL] [Abstract][Full Text] [Related]
22. The role of insulin-sensitive phosphodiesterase in insulin action.
Makino H; Suzuki T; Kajinuma H; Yamazaki M; Ito H; Yoshida S
Adv Second Messenger Phosphoprotein Res; 1992; 25():185-99. PubMed ID: 1372810
[TBL] [Abstract][Full Text] [Related]
23. Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis.
Omar B; Zmuda-Trzebiatowska E; Manganiello V; Göransson O; Degerman E
Cell Signal; 2009 May; 21(5):760-6. PubMed ID: 19167487
[TBL] [Abstract][Full Text] [Related]
24. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
Elks ML; Manganiello VC
Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
[TBL] [Abstract][Full Text] [Related]
25. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
[TBL] [Abstract][Full Text] [Related]
26. Stimulatory effect of vanadate on 3',5'-cyclic guanosine monophosphate-inhibited low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity in isolated rat fat pads.
Ueki H; Okuhama R; Sera M; Inoue T; Tominaga N; Morita T
Endocrinology; 1992 Jul; 131(1):441-6. PubMed ID: 1319324
[TBL] [Abstract][Full Text] [Related]
27. Evidence for the presence of essential histidine and cysteine residues in platelet cGMP-inhibited phosphodiesterase.
Ghazaleh FA; Omburo GA; Colman RW
Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):495-501. PubMed ID: 8713077
[TBL] [Abstract][Full Text] [Related]
28. Insulin and lipolytic hormones stimulate the same phosphodiesterase isoform in rat adipose tissue.
Boyes S; Loten EG
Biochem Biophys Res Commun; 1989 Jul; 162(2):814-20. PubMed ID: 2547376
[TBL] [Abstract][Full Text] [Related]
29. The antilipolytic effect of insulin does not require adenylate cyclase or phosphodiesterase action.
Gabbay RA; Lardy HA
FEBS Lett; 1985 Jan; 179(1):7-11. PubMed ID: 2981181
[TBL] [Abstract][Full Text] [Related]
30. Insulin induced phosphorylation and activation of the cGMP-inhibited cAMP phosphodiesterase in human platelets.
López-Aparicio P; Rascón A; Manganiello VC; Andersson KE; Belfrage P; Degerman E
Biochem Biophys Res Commun; 1992 Jul; 186(1):517-23. PubMed ID: 1321613
[TBL] [Abstract][Full Text] [Related]
31. Insulin activation of cyclic AMP phosphodiesterase in intact ureteral segments.
Weiss RM; Wheeler MA
J Pharmacol Exp Ther; 1988 Nov; 247(2):630-4. PubMed ID: 2846825
[TBL] [Abstract][Full Text] [Related]
32. The action of adenosine in relation to that of insulin on the low-Km cyclic AMP phosphodiesterase in rat adipocytes.
Wong EH; Ooi SO; Wong EH; Ooi SO; Loten EG; Sneyd JG
Biochem J; 1985 May; 227(3):815-21. PubMed ID: 2988506
[TBL] [Abstract][Full Text] [Related]
33. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle.
Murthy KS; Zhou H; Makhlouf GM
Am J Physiol Cell Physiol; 2002 Mar; 282(3):C508-17. PubMed ID: 11832336
[TBL] [Abstract][Full Text] [Related]
34. Antilipolytic action of insulin: role of cAMP phosphodiesterase activation.
Elks ML; Manganiello VC
Endocrinology; 1985 May; 116(5):2119-21. PubMed ID: 2985373
[TBL] [Abstract][Full Text] [Related]
35. Characterization of two recombinant PDE3 (cGMP-inhibited cyclic nucleotide phosphodiesterase) isoforms, RcGIP1 and HcGIP2, expressed in NIH 3006 murine fibroblasts and Sf9 insect cells.
Leroy MJ; Degerman E; Taira M; Murata T; Wang LH; Movsesian MA; Meacci E; Manganiello VC
Biochemistry; 1996 Aug; 35(31):10194-202. PubMed ID: 8756484
[TBL] [Abstract][Full Text] [Related]
36. Cellular tolerance to adenosine receptor-mediated inhibition of lipolysis: altered adenosine 3',5'-monophosphate metabolism and protein kinase activation.
Hoffman BB; Prokocimer P; Thomas JM; Vagelos R; Chang H; Reaven GM
Endocrinology; 1989 May; 124(5):2434-42. PubMed ID: 2539980
[TBL] [Abstract][Full Text] [Related]
37. Effects of okadaic acid on insulin-sensitive cAMP phosphodiesterase in rat adipocytes. Evidence that insulin may stimulate the enzyme by phosphorylation.
Shibata H; Robinson FW; Soderling TR; Kono T
J Biol Chem; 1991 Sep; 266(27):17948-53. PubMed ID: 1655732
[TBL] [Abstract][Full Text] [Related]
38. Examination of relative rates of cAMP synthesis and degradation in crude membranes of adipocytes treated with hormones.
Gettys TW; Okonogi K; Tarry WC; Johnston J; Horton C; Taylor IL
Second Messengers Phosphoproteins; 1990; 13(1):37-49. PubMed ID: 1962820
[TBL] [Abstract][Full Text] [Related]
39. Inhibition by glucagon of the cGMP-inhibited low-Km cAMP phosphodiesterase in heart is mediated by a pertussis toxin-sensitive G-protein.
Brechler V; Pavoine C; Hanf R; Garbarz E; Fischmeister R; Pecker F
J Biol Chem; 1992 Aug; 267(22):15496-501. PubMed ID: 1353495
[TBL] [Abstract][Full Text] [Related]
40. Insulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinase.
Wijkander J; Landström TR; Manganiello V; Belfrage P; Degerman E
Endocrinology; 1998 Jan; 139(1):219-27. PubMed ID: 9421418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
